Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20131988Phase 2Completed
A Phase 2 trial of Guchong in dysfunctional uterine bleeding (DUB), sponsored by Nanjing Dadong Pharmaceutical Technology. Started Nov 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20131988.